RARE-25. A RETROSPECTIVE, SINGLE INSTITUTION STUDY OF CENTRAL NEUROCYTOMA (2004-2016): SURVIVAL, TREATMENT, AND SUPPORTIVE CARE

OBJECTIVE: Central neurocytoma (WHO grade II) represents 0.25-0.5% of all primary brain tumors. Given its rarity, the management is typically described in small case series. We describe our institutional experience in terms of survival, treatment, pathologic correlates, and supportive care intervent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Johnson, Margaret O, Kirkpatrick, John P, Weant, Mallika P, Dunn-Pirio, Anastasie, Desjardins, Annick, Randazzo, Dina, Friedman, Henry S, Peters, Katherine B
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692623/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.871
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados